Home - Products - Others - Other Targets - Hypertrehalosaemic Neuropeptide, Nauphoeta cinerea

Hypertrehalosaemic Neuropeptide, Nauphoeta cinerea

CAS No. 106018-36-4

Hypertrehalosaemic Neuropeptide, Nauphoeta cinerea( ——— )

Catalog No. M41455 CAS No. 106018-36-4

Hypertrehalosemic neuropeptide (Nauphoeta cinerea) is a neuropeptide in the adipokinetic hormone/red pigment-concentrating hormone (AKH/RPCH) family, and can stimulate the synthesis of trehalose.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Hypertrehalosaemic Neuropeptide, Nauphoeta cinerea
  • Note
    Research use only, not for human use.
  • Brief Description
    Hypertrehalosemic neuropeptide (Nauphoeta cinerea) is a neuropeptide in the adipokinetic hormone/red pigment-concentrating hormone (AKH/RPCH) family, and can stimulate the synthesis of trehalose.
  • Description
    Hypertrehalosemic neuropeptide (Nauphoeta cinerea) is a neuropeptide in the adipokinetic hormone/red pigment-concentrating hormone (AKH/RPCH) family, and can stimulate the synthesis of trehalose.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    106018-36-4
  • Formula Weight
    1074.19
  • Molecular Formula
    C50H67N13O14
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lewis DK, et al. Hypertrehalosemic hormone in a cockroach: molecular cloning and expression. Mol Cell Endocrinol. 1997;130(1-2):101-108.?
molnova catalog
related products
  • SU 5205

    SU 5205 is a VEGFR2 inhibitor.

  • Mupadolimab

    Mupadolimab (CPI-006) is a humanized FC-γR binding deficient IgG1 anti-CD73 antibody with potential anticancer activity and activation of CD73POS B cells.

  • Pasireotide Acetate

    Pasireotide Acetate is a stable cyclohexapeptide somatostatin mimic.